News

2021

 

• September 20, 2021

  Discovery on Target 2021 : Domain Therapeutics to present its latest developments and research

  Read more
• June 18, 2021

  SLAS Europe 2021 : Domain Therapeutics to present a poster about its powerful BRET-based platform dedicated to the study of immune checkpoint co-receptors.

  Read more
• May 11, 2021

  [ video ] The IRIC Virtual Symposium on June 4 : “GPCRs In Oncology & Immuno-oncology” – Sponsored by Domain Therapeutics

  Read more
• April 23, 2021

  ASPET annual meeting 2021 : Domain Therapeutics to present its poster selected as a Program Committee Blue Ribbon Pick

  Read more
• April 20, 2021

  Bloom Burton & Co. Healthcare Investor Conference 2021 : Pascal Neuville, CEO of Domain Therapeutics, to present our latest advances !

  Read more
• April 1, 2021

  AACR 2021 : Domain Therapeutics to present posters on last developments in the field of oncology

  Read more
• March 17, 2021

  Join our free webinar : The discovery and challenges of antibodies targeting GPCRs on april 20, 2021 at 03 pm CEST

  Read more
• March 11, 2021

  Bio-Europe Spring 2021

  Read more
• January 4, 2021

  Domain Therapeutics to participate in the J.P. Morgan 39th Annual Healthcare Conference 2021 DIGITAL

  Read more

2020

 

• December 1, 2020

  Meet&Match 2020 immuno-oncology

  Read more
• October 20, 2020

  BIO-EUROPE 2020 digital meeting

  Read more
• October 13, 2020

  Join our free webinar : Innovative Technology for Insights into Receptor Tyrosine Kinase Biology on Oct. 29, 2020 at 11 am EST

  Read more
• October 5, 2020

  Domain therapeutics webinar : Shedding New Light on GPCR Drug Discovery with a Novel Biosensor Technology

  Read more
• September 8, 2020

  Join our free webinar : Shedding new light on GPCR drug discovery with a novel biosensor technology on Sept. 29, 2020 at 11 am EST

  Read more
• June 19, 2020

  Domain presents the last generation of bioSens-All™ platform dedicated to checkpoint inhibitors at the AACR 2020

  Read more
• June 19, 2020

  Domain presents a novel approach to study RTK mutations and the effects of inhibitors at the AACR 2020

  Read more
• June 19, 2020

  Domain presents target identification strategy to identify novel immune checkpoint from GPCR-ome at the AACR 2020

  Read more
• June 19, 2020

  Domain presents the best-in-class potential of its EP4 antagonist drug candidate at the AACR 2020

  Read more
• June 10, 2020

  Domain Therapeutics contributes to the launch of Find Therapeutics

  Read more
• June 9, 2020

  DOMAIN at the BIO Digital conference 2020

  Read more
• April 10, 2020

  Domain at the BioTrinity 2020 digital conference

  Read more
• January 13, 2020

  Domain at the JP Morgan Healthcare conference

  Read more